Australia: Herry joins AcuraBio as CEO to support global growth plans

AcuraBio CEO Guillaume Herry

Australian biopharmaceutical CDMO, AcuraBio, has named Guillaume Herry as CEO in its efforts to support global growth plans. Herry brings over 15 years of international operational and strategic consulting experience across the biopharmaceutical and medical device industries in companies based in the US, Europe and Australia. “I’m excited to be part of this new phase…

You must be a HMI Subscriber to view this content.

Subscribe Now »